MMRGlobal Launches Platinum Service, New Direct-To-Consumer Revenue Stream

LOS ANGELES, CA--(Marketwire - Dec 17, 2012) -   MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and MMRPro document management and imaging systems for healthcare professionals, today announced that it is offering a special MMR Platinum service which is replacing the MedicAlert® Gold ("MAGold") service that has been powered by MyMedicalRecords for more than six years. MAGold only covered one MedicAlert member per account and provided less than half the features and benefits of the Company's patented MyMedicalRecords Personal Health Record (PHR). The new MMR Platinum service includes all the features of MyMedicalRecords, with service for up to ten family members including pets. Platinum also includes transitioning an existing MAGold member account at no additional cost including assistance in getting an entire family's medical records loaded into an account. MMR Platinum is sold direct-to-consumer and the service is currently being advertised monthly in MedicAlert newsletters to hundreds of thousands of current and past MedicAlert subscribers. Since launching MMR Platinum less than one month ago, the Company has received nearly $30,000 in MedicAlert related revenue.

MMRGlobal is the owner and the Company's CEO Robert H. Lorsch is the inventor of five currently issued United States patents and others that are issued, pending and/or applied for in at least 12 countries around the world. The patents are related, in general, to the provisioning of Personal Health Records and Electronic Health Records and are U.S. Patent Nos. 8,121,855; 8,117,646; 8,117,045; 8,301,466 and 8,321,240. MMR also has numerous additional patent applications pending related to patient information and Personal Health Records. Recent activity in health information technology evidences the significant awareness, interest and value in health IT patents which should increase as the industry approaches Stage 2 Meaningful Use requirements in 2014 and continues to mature. The Company believes that its existing patents could make it difficult for eligible healthcare professionals to fully qualify for incentives under the HITECH Act without a license from MMR since one of the requirements is to provide patients access to their personal health information through a Web-based portal or PHR.

MMR Platinum subscribers also get an emergency portal that displays potentially life-saving information and comprehensive family health histories that can be accessed by physicians and emergency responders. Also included in each Platinum account are secondary passwords on four virtual safe deposit boxes for advance directives, DNRs, wills and other important emergency documents. Each Platinum account uses MyMedicalRecords' technologies to enable users to receive communications from their doctors and other healthcare providers. Information in an account can also easily be shared with caregivers and authorized family members. Additionally, the system includes the ability to calendar doctor appointments, medication reminders and prescription refills that synchronize with Microsoft® Outlook®. Reminder alerts can automatically get sent from the account to as many as three locations and include text messages at the option of the user. To easily share information in the account with physicians or caretakers, members can fax and email records directly from inside the account. Users also have the ability to upload and store x-rays, medical images, and insurance documents. 

MMR Platinum includes MyMedicalRecords' proprietary document management system with 16 separate file folders as well as an online patient education directory of more than 3,000 health conditions. A drug database also provides information on over 20,000 prescription and over-the-counter medications with the added feature of a drug interaction tool that can automatically check for interactions between medications the user is taking.

About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including, without limitation, future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes of intellectual property enforcement actions, infringement claims, litigation or licensing transactions, results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; acceptance of new product, service and promotional offerings, including MMR Platinum; the timing and volume of sales and installations; the length of sales cycles and the installation process; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.